Works about MITOXANTRONE

Results: 327
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Outcome of poor response paediatric AML using early SCT.

    Published in:
    European Journal of Haematology, 2013, v. 90, n. 3, p. 187, doi. 10.1111/ejh.12051
    By:
    • Wareham, Neval E.;
    • Heilmann, Carsten;
    • Abrahamsson, Jonas;
    • Forestier, Erik;
    • Gustafsson, Britt;
    • Ha, Shau‐Yin;
    • Heldrup, Jesper;
    • Jahnukainen, Kirsi;
    • Jónsson, Ólafur G.;
    • Lausen, Birgitte;
    • Palle, Josefine;
    • Zeller, Bernward;
    • Hasle, Henrik
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Dynamic and Assembly Characteristics of Deep‐Cavity Basket Acting as a Host for Inclusion Complexation of Mitoxantrone in Biotic and Abiotic Systems.

    Published in:
    Chemistry - A European Journal, 2023, v. 29, n. 68, p. 1, doi. 10.1002/chem.202303374
    By:
    • Pavlović, Radoslav Z.;
    • Finnegan, Tyler J.;
    • Metlushko, Anna;
    • Hansen, Alexandar L.;
    • Waudby, Christopher A.;
    • Wang, Xiuze;
    • Hoefer, Nicole;
    • McComb, David W.;
    • Pavić, Aleksandar;
    • Plackić, Nikola;
    • Novaković, Jovana;
    • Bradić, Jovana;
    • Jeremić, Nevena;
    • Jakovljević, Vladimir;
    • Šmit, Biljana;
    • Matić, Sanja;
    • Alvarez‐Saavedra, Matias A.;
    • Čapo, Ivan;
    • Moore, Curtis E.;
    • Stupp, Samuel I.
    Publication type:
    Article
    24

    Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations.

    Published in:
    Archives of Toxicology, 2020, v. 94, n. 12, p. 4067, doi. 10.1007/s00204-020-02874-4
    By:
    • Costa, Vera Marisa;
    • Capela, João Paulo;
    • Sousa, Joana R.;
    • Eleutério, Rute P.;
    • Rodrigues, Patrícia R. S.;
    • Dores-Sousa, José Luís;
    • Carvalho, Rui A.;
    • Lourdes Bastos, Maria;
    • Duarte, José Alberto;
    • Remião, Fernando;
    • Almeida, M. Gabriela;
    • Varner, Kurt J.;
    • Carvalho, Félix
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3371, doi. 10.1002/cam4.2865
    By:
    • Gill, Harinder;
    • Yim, Rita;
    • Pang, Herbert H.;
    • Lee, Paul;
    • Chan, Thomas S. Y.;
    • Hwang, Yu‐Yan;
    • Leung, Garret M. K.;
    • Ip, Ho‐Wan;
    • Leung, Rock Y. Y.;
    • Yip, Sze‐Fai;
    • Kho, Bonnie;
    • Lee, Harold K. K.;
    • Mak, Vivien;
    • Chan, Chi‐Chung;
    • Lau, June S. M.;
    • Lau, Chi‐Kuen;
    • Lin, Shek‐Yin;
    • Wong, Raymond S. M.;
    • Li, Wa;
    • Ma, Edmond S. K.
    Publication type:
    Article
    31

    Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

    Published in:
    Cancer Medicine, 2019, v. 8, n. 16, p. 6955, doi. 10.1002/cam4.2555
    By:
    • Peñalver, Francisco‐Javier;
    • Márquez, José‐Antonio;
    • Durán, Soledad;
    • Giraldo, Pilar;
    • Martín, Alejandro;
    • Montalbán, Carlos;
    • Sancho, Juan‐Manuel;
    • Ramírez, María‐José;
    • Terol, María‐José;
    • Capote, Francisco‐Javier;
    • Gutiérrez, Antonio;
    • Sánchez, Blanca;
    • López, Andrés;
    • Salar, Antonio;
    • Rodríguez‐Caravaca, Gil;
    • Canales, Miguel;
    • Caballero, María‐Dolores
    Publication type:
    Article
    32

    90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years.

    Published in:
    Cancer Medicine, 2016, v. 5, n. 6, p. 1093, doi. 10.1002/cam4.684
    By:
    • Casadei, Beatrice;
    • Pellegrini, Cinzia;
    • Pulsoni, Alessandro;
    • Annechini, Giorgia;
    • De Renzo, Amalia;
    • Stefoni, Vittorio;
    • Broccoli, Alessandro;
    • Gandolfi, Letizia;
    • Quirini, Federica;
    • Tonialini, Lorenzo;
    • Morigi, Alice;
    • Argnani, Lisa;
    • Zinzani, Pier Luigi
    Publication type:
    Article
    33

    A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.

    Published in:
    2021
    By:
    • Zeidner, Joshua F.;
    • Lin, Tara L.;
    • Vigil, Carlos E.;
    • Fine, Gil;
    • Yair Levy, M.;
    • Nazha, Aziz;
    • Esteve, Jordi;
    • Lee, Daniel J.;
    • Yee, Karen;
    • Dalovisio, Andrew;
    • Wang, Eunice S.;
    • Bergua Burgues, Juan M.;
    • Schriber, Jeffrey;
    • Litzow, Mark R.;
    • Frankfurt, Olga;
    • Castillo, Teresa Bernal Del;
    • Bhatt, Vijaya Raj;
    • Bhatnagar, Bhavana;
    • Mehta, Priyanka;
    • Dillon, Richard
    Publication type:
    Letter
    34
    35
    36
    37
    38
    39
    40
    41

    High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk Acute Myeloid Leukemia (AML).

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 3, p. 445, doi. 10.3109/10428194.2011.621562
    By:
    • Larson, Sarah M.;
    • Campbell, Nicholas P.;
    • Huo, Dezheng;
    • Artz, Andrew;
    • Zhang, Yanming;
    • Gajria, Devika;
    • Green, Margaret;
    • Weiner, Howie;
    • Daugherty, Christopher;
    • Odenike, Olatoyosi;
    • Godley, Lucy A.;
    • Hyjek, Elizabeth;
    • Gurbuxani, Sandeep;
    • Thirman, Michael;
    • Sipkins, Dorothy;
    • van Besien, Koen;
    • Larson, Richard A.;
    • Stock, Wendy
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50